3/29
08:43 am
harp
Harpoon Therapeutics, Inc. (NASDAQ: HARP) had its price target lowered by analysts at HC Wainwright from $7.00 to $4.50.
Low
Report
Harpoon Therapeutics, Inc. (NASDAQ: HARP) had its price target lowered by analysts at HC Wainwright from $7.00 to $4.50.
3/27
04:05 pm
harp
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Low
Report
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
3/27
04:02 pm
harp
Harpoon Therapeutics Announces Closing of $25 Million Private Placement
Low
Report
Harpoon Therapeutics Announces Closing of $25 Million Private Placement
3/14
06:21 pm
harp
Harpoon Therapeutics Announces Acceptance of Five Abstracts for Presentation at AACR Annual Meeting 2023
High
Report
Harpoon Therapeutics Announces Acceptance of Five Abstracts for Presentation at AACR Annual Meeting 2023
2/7
07:30 am
harp
Harpoon Therapeutics to Participate in the SVB Securities Global Biopharma Conference
High
Report
Harpoon Therapeutics to Participate in the SVB Securities Global Biopharma Conference